Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism Mas receptor agonists(Proto-oncogene Mas agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia | Phase 2 | US | 12 Oct 2010 | |
Marfan Syndrome | Discovery | US | 06 Feb 2014 | |
Muscular Dystrophies | Discovery | US | 06 Feb 2014 | |
Peripheral Vascular Diseases | Discovery | US | 05 Mar 2013 | |
Stroke | Discovery | US | 05 Mar 2013 | |
Diabetes Mellitus | Discovery | US | 30 Nov 2012 | |
Perioperative ischaemia | Discovery | US | 30 Nov 2012 | |
Lung Diseases | Discovery | US | 31 Oct 2011 | |
Neutropenia | Discovery | US | 12 Oct 2010 | |
Thrombocytopenia | Discovery | US | 12 Oct 2010 |